UQDI Seminar Series 

Presented by: Associate Professor Jake Shortt, School of Clinical Sciences, Monash University

Title: Next generation targeting of DNA methylation in T-cell lymphoma

Bio: A/Prof Jake Shortt is the Head of Haematology Research at Monash University School of Clinical Sciences and a Consultant Haematologist at Monash Health.  He trained in haematology at the Alfred Hospital before undertaking a PhD in cancer therapeutics at the Peter MacCallum Cancer Centre. He is the clinical lead at Monash for leukaemia and myelodysplasia.  A/Prof Shortt heads the Blood Cancer Therapeutics Laboratory within the new Monash Health Translation Precinct where his laboratory focuses on epigenetic and immunological treatments for haematological malignancies – in particular lymphoma and multiple myeloma.  In addition to his preclinical work, he is a principal investigator on a range of phase 1-3 clinical trials, an investigator for the Melbourne Genomics Health Alliance ‘Aggressive Lymphoma Flagship’ and chair of the Australasian Leukaemia & Lymphoma Group laboratory sciences committee.

See here for more about A/Prof Shortt